Drug recall · July 19, 2017
Paroxetine Extended-Release Tablets USP recall
Why: Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06
- Lots / codes
Lots: H605712, H605711, H605710, EXP November 2018; H702255, H702202 EXP March 2019
- Quantity
- 12480 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Nationwide in the USA
- Initiated
- June 22, 2017 · Voluntary: Firm initiated
- Classified
- July 12, 2017
- Reported
- July 19, 2017
- Ended
- January 17, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Paroxetine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.